What is Ciwit B.V.?
Ciwit B.V., operating as Castor EDC, is a prominent clinical data management company specializing in electronic data capture (EDC) systems for clinical research and medical studies. The company provides a cloud-based software solution that empowers researchers to meticulously design case report forms, efficiently collect patient data, and comprehensively manage clinical trial information. Castor EDC serves a diverse clientele, including pharmaceutical companies, contract research organizations (CROs), academic institutions, and healthcare providers engaged in clinical research. Its user-friendly EDC technology is instrumental in ensuring regulatory compliance, maintaining high data quality standards, and optimizing the overall efficiency of clinical trial management, positioning it as a key player in advancing medical research through robust data infrastructure.
How much funding has Ciwit B.V. raised?
Ciwit B.V. has raised a total of $58.2M across 3 funding rounds:
Grant
$1.2M
Series A
$12M
Series B
$45M
Grant (2017): $1.2M, investors not publicly disclosed
Series A (2020): $12M led by INKEF Capital, Two Sigma Ventures, and Hambrecht Ducera Growth Ventures
Series B (2021): $45M supported by Two Sigma Ventures, INKEF Capital, F-Prime Capital Partners, and Eight Roads
Key Investors in Ciwit B.V.
Two Sigma Ventures
Two Sigma Ventures is an early-stage venture capital firm that invests in transformative companies leveraging information growth and computing power. The firm focuses on technology that enhances human potential, breakthrough therapies, artificial intelligence, and online safety for children.
INKEF Capital
INKEF Capital is an Amsterdam-based venture capital firm that focuses on long-term collaboration and active support of innovative technology companies. INKEF focuses on investment opportunities in Healthcare, Technology, IT/New Media & FinTech.
F-Prime Capital Partners
Founded in 2002, F-Prime Capital provides a team of investors, engineers, doctors, and scientists dedicated to investing in health care and technology for other companies. F-Prime Capital is located in Massachusetts.
What's next for Ciwit B.V.?
The substantial enterprise-level funding Ciwit B.V. has attracted signals a strong trajectory for scaling its operations and further innovating its clinical data management platform. With this strategic investment, the company is well-positioned to expand its market reach, enhance its technological capabilities, and potentially explore new verticals within the healthcare and life sciences industries. The consistent backing from notable investors like Two Sigma Ventures and INKEF Capital suggests confidence in Ciwit B.V.'s long-term vision and its capacity to drive significant advancements in clinical research efficiency and data integrity.
See full Ciwit B.V. company page
